Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Healius Limited (HLS) vs. Competitors

69 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:HLSHealius LimitedAUD 0.54AUD 381.24M-0.94-40.66%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:LDXLumos Diagnostics Holdings Ltd.AUD 0.07AUD 72.14M-7.43-66.98%Moderate BuyUnlock the AU:LDX analyst price target with TipRanks PremiumAU:HLS vs AU:LDXUnlock the AU:LDX top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 19.92AUD 9.80B16.20-5.73%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:HLS vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.70AUD 634.92M28.91-34.11%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:HLS vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.33AUD 619.24M26.9423.33%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:HLS vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium
AU:MVFMonash IVF Group LtdAUD 0.76AUD 300.02M39.5317.97%Moderate BuyUnlock the AU:MVF analyst price target with TipRanks PremiumAU:HLS vs AU:MVFUnlock the AU:MVF top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:HLSHealius Limited0.54-0.35-39.33%
AU:LDXLumos Diagnostics Holdings Ltd.0.07-0.13-64.50%
AU:SHLSonic Healthcare Limited19.92-0.32-1.60%
AU:IDXIntegral Diagnostics Ltd.1.70-0.69-28.93%
AU:ACLAustralian Clinical Labs Ltd3.330.7729.82%
AU:MVFMonash IVF Group Ltd0.760.1728.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts